Video Experimental Relacionado
Updated: Sep 9, 2025

05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
10.1K
Los pegamentos moleculares y los PROTAC en la degradación dirigida de proteínas: mecanismos, avances y potencial
1Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Biochemical pharmacology
|September 4, 2025
Resumen
La degradación proteica dirigida (TPD) utiliza los sistemas del cuerpo para eliminar las proteínas que causan enfermedades. Los pegamentos moleculares y los PROTAC son dos métodos TPD que ofrecen nuevas posibilidades terapéuticas.
Área de la Ciencia:
- La bioquímica
- Biología molecular
- Farmacología
Sus antecedentes:
- La degradación proteica dirigida (TPD) ofrece una nueva estrategia terapéutica.
- Elimina selectivamente proteínas específicas, a diferencia de los inhibidores tradicionales.
- La TPD amplía el alcance de los objetivos farmacológicos, incluidas las proteínas anteriormente intratables.
Objetivo del estudio:
- Proporcionar una visión comparativa de los pegamentos moleculares y los PROTAC.
- Para discutir sus mecanismos, principios de diseño y aplicaciones terapéuticas.
- Para resaltar los avances recientes y el progreso clínico en TPD.
Principales métodos:
- Análisis comparativo de los pegamentos moleculares y los PROTAC.
- Revisión de los mecanismos, el diseño y las propiedades fisicoquímicas.
- Examen de los avances clínicos y de los estudios de caso.
Principales resultados:
- Los gluos moleculares y los PROTAC representan estrategias distintas de TPD.
- Ambas modalidades han expandido el proteoma farmacológico.
- Los avances recientes están acelerando el descubrimiento de nuevos degradantes.
Conclusiones:
- TPD, a través de Molecular Glues y PROTACs, está cambiando el descubrimiento de fármacos.
- Estos enfoques son muy prometedores para el tratamiento de diversas enfermedades.
- La investigación en curso y los ensayos clínicos están impulsando la innovación terapéutica.
Videos de Conceptos Relacionados
Regulated Protein Degradation
2.6K
2.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tagging and Fusion Proteins
6.9K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.9K
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K

